Ishita Drugs & Industries Ltd.

View in App
67.00 +0.19 ▲0.3%

04 October 2023, 02:15:00 PM
Volume: 1,783

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ishitadrugs.com
Market Cap 19.98 Cr.
Enterprise Value(EV) 17.51 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.84 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 36.40 Trailing Twelve Months Ending 2023-06
Industry PE 38.26 Trailing Twelve Months Ending 2023-06
Book Value / Share 31.13 Trailing Twelve Months Ending 2023-06
Price to Book Value 2.15 Calculated using Price: 66.82
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.30 Cr. 2,990,300 Shares
FaceValue 10
About Ishita Drugs & Industries Ltd.
Ishita drugs & industries limited (IDIL), an Ishita Group company was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

Ishita Drugs & Industries Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Ishita Drugs & Industries Ltd. Performance

View details >>
1 Day
+0.28%
1 Week
-7.47%
1 Month
-1.47%
3 Month
-16.42%
6 Month
+36.76%
1 Year
+15.72%
2 Year
+67.50%
5 Year
+332.26%
10 Year
+129.45%

Ishita Drugs & Industries Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 4.12 2.47 3.19 4.17 5.64 8.18 11.25 9.82 6.50
Return on Capital Employed (%) 5.98 4.02 4.79 7.26 8.17 10.79 14.39 13.00 8.90
Return on Assets (%) 3.26 1.81 2.37 3.46 4.54 6.12 8.82 7.85 5.10

Ishita Drugs & Industries Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 5 5 6 6 6 6 7 8 9 9
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 1 1 3 1 1 2 3 1 3 2
Minority Int.
Equity & Liab. 7 7 8 7 7 8 10 9 11 11
Non Curr. Assets 2 1 1 1 1 2 1 1 1 1
Curr. Assets 5 6 7 6 6 7 8 8 10 10
Misc. Exp. not W/O
Total Assets 7 7 8 7 7 8 10 9 11 11

Ishita Drugs & Industries Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 7 7 6 7 9 15 14 14 12 12
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 7 7 6 7 9 15 14 14 12 12
Total Expenditure -7 -6 -6 -6 -9 -14 -13 -13 -11 -11
PBIDT 0 0 0 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 1 1 1 1 1
Adjusted EPS 1 0 1 1 1 2 3 3 2 2

Ishita Drugs & Industries Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 0 0 1 1 1 1 -1 3 -3
Cash Fr. Inv. 0 0 0 -1 -1 -1 -1 2 -1 1
Cash Fr. Finan. 0 0 1 -1 0 0 0 0 1
Net Change 0 0 1 -1 0 0 0 2 2 -1
Cash & Cash Eqvt 1 1 2 1 1 1 1 3 5 3

Ishita Drugs & Industries Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 47.87 47.87 48.37 49.31 49.32 49.32 49.32 49.38 49.38
Public 52.13 52.13 51.63 50.69 50.68 50.68 50.68 50.62 50.62
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Ishita Drugs & Industries Ltd. Announcements

View details >>
Sat, 30 Sep 2023
Closure of Trading Window
The trading window for dealing in securities of the Company by Designated Persons stands closed from Sunday 1st October 2023 till 48 hours after the declaration of the Unaudited Financial Results for the quarter and half-year ended 30th September 2023 to the Stock Exchange.
Fri, 29 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Disclosure of Voting Results and Scrutinizers Report for 30th Annual General Meeting of the Company held on 27th September 2023.
Thu, 28 Sep 2023
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Pursuant to the provision of section 139 142 and other applicable provisions if any of the companies act 2013 and the rules framed there under as amended from time to time the Company hereby appoints M/s. Jaymin Shah & Associates Chartered Accountant (FRN No : 129406W) as the Statutory Auditors of the Company for the Financial Year 2023-24.

Ishita Drugs & Industries Ltd. Technical Scans

View details >>
Tue, 03 Oct 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
Opening at Low Opening at Low
Opening at High for 3 days Opening at High for 3 days

Ishita Drugs & Industries Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 273,992.06 1,122.80 -1.6%
Divi's Laboratories Ltd. 98,792.80 3,691.20 -0.9%
Cipla Ltd. 95,478.34 1,166.20 -1.4%
Dr. Reddy's Laboratories Ltd. 91,061.15 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. 73,583.24 5,038.30 -1.6%
Mankind Pharma Ltd. 72,079.88 1,802.05 +0.2%
Torrent Pharmaceuticals Ltd. 63,636.20 1,860.70 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.48 1,122.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-06 66.87 3,691.20 -0.9%
Cipla Ltd. Consolidated 2023-06 30.69 1,166.20 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.28 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.06 5,038.30 -1.6%
Mankind Pharma Ltd. Consolidated 2023-03 56.25 1,802.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.53 1,860.70 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.72 1,122.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-06 7.53 3,691.20 -0.9%
Cipla Ltd. Consolidated 2023-06 3.92 1,166.20 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.71 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.73 5,038.30 -1.6%
Mankind Pharma Ltd. Consolidated 2023-03 5.89 1,802.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.68 1,860.70 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,122.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,691.20 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,166.20 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,038.30 -1.6%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,802.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,860.70 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,122.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,691.20 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,166.20 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,038.30 -1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,802.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,860.70 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,122.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,691.20 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,166.20 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,038.30 -1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,802.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,860.70 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,122.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,691.20 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,166.20 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,038.30 -1.6%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,802.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,860.70 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,122.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,691.20 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,166.20 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,038.30 -1.6%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,802.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,860.70 -1.0%

Ishita Drugs & Industries Ltd. FAQ's

What is Ishita Drugs & Inds. share price?
Can I buy Ishita Drugs & Inds. shares now?
What is the Market Cap of Ishita Drugs & Inds.?
What are the key metrics to analyse Ishita Drugs & Inds.?
What is the 52 Week High and Low of Ishita Drugs & Inds.?
What is the trend of Ishita Drugs & Inds. share price?